TOKYO, May 15 (Pulse News Wire) – Kohjin Bio Co., Ltd. (177A.T) reported consolidated results for fiscal year 2026 ending March.
Revenue was ¥4.9 billion (-5.1% YoY). operating profit was ¥341 million (-65.5%). net profit attributable to shareholders was ¥251 million (-68.4%).
Total assets stood at ¥8.9 billion with an equity ratio of 66.8%. The company declared an annual dividend of ¥10 per share. The full-year forecast for the current fiscal year is revenue of ¥4.7 billion.
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥4,939M | -5.1% |
| Operating profit | ¥341M | -65.5% |
| Net profit | ¥251M | -68.4% |
Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.